Cindy Whitehead is founder and CEO of The Pink Ceiling, a Raleigh, NC-based organization that invests in businesses focusing on entrepreneurial breakthroughs on issues affecting women in the U.S. and around the world. A leading women’s health advocate and entrepreneur, Whitehead is passionate about matching the latest in science/technology with important unmet consumer needs. With a 22-year track record in healthcare, Whitehead is a best known for building and selling pharmaceutical businesses that deliver industry record-setting returns. She co-founded and previously served as CEO for the Sprout Pharmaceuticals. In 2015, the company broke through with the first ever FDA-approved drug, Addyi, for low sexual desire in women - dubbed "female Viagra" by the media. She also co-founded and led all operational functions at Slate Pharmaceuticals, which commercialized the first FDA-approved, long-acting testosterone preparation for men, Testopel, in the field of sexual medicine. A serial entrepreneur, Whitehead has been recognized by Entrepreneur Magazine as one of 2016’s "Women to Watch.” Her work has been featured across all major media outlets: The New York Times, Associated Press, Financial Times, CNBC, among others. She is also a frequent lecturer at conferences including Fast Company Innovation Festival, Chicago Ideas and Fortune’s Next Gen Most Powerful Women Summit.